The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.
about
Slow-release oral morphine as maintenance therapy for opioid dependencePharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature.Long term outcomes of pharmacological treatments for opioid dependence: does methadone still lead the pack?Methadone induction in primary care for opioid dependence: a pragmatic randomized trial (ANRS Methaville).New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone.Barriers to use of pharmacotherapy for addiction disorders and how to overcome them.French Experience with Buprenorphine : Do Physicians Follow the Guidelines?Hyperalgesia in heroin dependent patients and the effects of opioid substitution therapy.A placebo-controlled trial of dextromethorphan as an adjunct in opioid-dependent patients undergoing methadone maintenance treatmentBudgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain.First-time admissions for opioid treatment: cross-sectional and descriptive study of new opioid users seeking treatment.Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone.Training in Substance-Related and Addictive Disorders, Part 1: Overview of Clinical Practice and General Recommendations.Human resource development and capacity-building during China's rapid scale-up of methadone maintenance treatment services.Factors associated with mortality of HIV-positive clients receiving methadone maintenance treatment in China.Naltrexone extended-release injection: an option for the management of opioid abuse.Buprenorphine and buprenorphine/naloxone soluble-film for treatment of opioid dependence.Buprenorphine use in pregnant opioid users: a critical review.Buprenorphine-naloxone buccal soluble film for the treatment of opioid dependence: current update.Pharmacological Management of Opioid Use Disorder in Pregnant Women.Six-Year Outcome of Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic Study in a Nationally Representative Sample.High Concomitant Misuse of Fentanyl in Subjects on Opioid Maintenance Treatment.Role of GIRK channels on the noradrenergic transmission in vivo: an electrophysiological and neurochemical study on GIRK2 mutant mice.Commentary on Hser et al. (2014): to retain or not to retain-open questions in opioid maintenance therapy.Experience of social discrimination correlates with neurometabolism: a pilot study in heroin addicts.The worldwide opioid epidemic: implications for treatment and research in pregnancy and the newborn.Buprenorphine-naloxone treatment in opioid dependence and risk of liver enzyme elevation: results from a 12-month observational study.Formation sur les troubles d’utilisation de substances et troubles addictifs, 1re partie : Survol de la pratique clinique et recommandations générales.Treatment of opioid dependence with buprenorphine: current update.Factors associated with depression and anxiety among patients attending community-based methadone maintenance treatment in China.Commentary on Rosenthal et al. (2013): Buprenorphine implant-new hopes, old questions.[Driving ability with alcohol and drug dependence and schizophrenia].A Comparison of Cognitive Function in Patients under Maintenance Treatment with Heroin, Methadone, or Buprenorphine and Healthy Controls: An Open Pilot StudyAssessing the validity and reliability of the Turkish versions of craving beliefs and beliefs about substance use questionnaire in patients with heroin use disorder: demonstrating valid tools to assess cognition-emotion interplay
P2860
Q24202258-07D8EE64-89A5-4AAA-8DD0-30DFB542F0ECQ33582063-B5E77296-BDA8-46FF-9175-C4124E6A41E0Q33582068-C663482B-8C0B-4477-8383-4FA60F0D4F90Q34506560-9374B262-90FB-4175-B58E-B70C8D794709Q34952233-1E9A1B78-D659-4506-8159-B642373B21DFQ35490468-78681D1E-76F9-4693-BEC2-5226ADB3D5AAQ35812155-36599E19-7B17-4B5C-9A3E-418783343C91Q35906902-15FB524F-AD4C-4718-8204-ABF96D126914Q35965884-55490215-381E-4EA2-BA19-C5DD5B05DCFCQ36110773-9060B58D-769B-4559-BDB5-102822769939Q36111594-70A26D27-2B25-4899-9E25-FB2560CF289AQ36345193-7E0FEDEC-61E5-48F4-89E9-43DC298C934FQ36371855-2B28B5B8-767D-4F1D-B035-D264424F2C16Q36706991-CBA7B230-66CA-4375-A6D7-F9C670029357Q36974887-B841F1FD-D4A9-4946-8ACC-4185302BBF76Q37355293-05048EAC-5CAC-4AD9-9AC6-7FCE96EAA98AQ38046650-88F25B89-83C7-4D8A-80E0-991384F041A3Q38115201-32AC5E7B-9D70-4739-9C57-631BAF97BE18Q38243268-F315EE6B-E1D1-4045-9018-9F27061ECDB6Q38575591-BCBC4206-99C7-4BFC-8559-4C06EC4033E3Q38855420-8F530418-4136-4B70-89DE-2788438A4334Q38981201-F67022CA-1E86-459E-B6EC-BB2B33F32FACQ42513774-7A09DB9F-85EA-4001-8A1E-71CC15FA8F0DQ42638163-D6DA8E57-C314-4E51-8C3D-A445AD6C4AEFQ43433160-9D4EAF95-C7F4-4AA7-A4FA-305C6F28EB53Q44330446-2802E56B-0BC0-4E9B-9A2B-828EC2E42AD3Q44347273-05F08B70-2F6A-44F1-93A5-6BC3EAB0FC94Q46176682-F1DE898A-CBAA-426F-9B1C-64B01BDFD15EQ47133543-390739D4-5655-43F0-9CFA-04FCE4BB088EQ47768718-D8A21964-6D00-43B5-A68D-216FFBD85A59Q52303526-E188DB58-370B-4C88-8C0A-F3D1FDF7D1DEQ52304840-56C74B77-95C9-42A1-AABF-4DF5EE6C2C7FQ58242031-F621375F-6F4B-4175-BF39-FEF0873E67E1Q58721125-4210CE98-EAA4-4424-B33C-447129572A3A
P2860
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The World Federation of Societ ...... rs. Part 2: Opioid dependence.
@ast
The World Federation of Societ ...... rs. Part 2: Opioid dependence.
@en
type
label
The World Federation of Societ ...... rs. Part 2: Opioid dependence.
@ast
The World Federation of Societ ...... rs. Part 2: Opioid dependence.
@en
prefLabel
The World Federation of Societ ...... rs. Part 2: Opioid dependence.
@ast
The World Federation of Societ ...... rs. Part 2: Opioid dependence.
@en
P2093
P2860
P1476
The World Federation of Societ ...... rs. Part 2: Opioid dependence.
@en
P2093
Henry R Kranzler
John Krystal
Michael Soyka
WFSBP Task Force on Treatment, Guidelines for Substance Use Disorders
Wim van den Brink
P2860
P304
P356
10.3109/15622975.2011.561872
P577
2011-04-01T00:00:00Z